Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | CNR1 | P21554 | 1/20 | 0.38 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.35 |
| ▸ | DPP4 | P27487 | 1/20 | 0.35 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.35 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.33 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.33 |
| ▸ | BIRC2 | Q13490 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5812170 | 1.00 | TSHR (0.42) | TSHRCNR1DAGLACA12CA14 | |
| SCHEMBL30698078 | 0.87 | TSHR (0.35) | TSHRCNR1DAGLACA12CA14 | |
| SCHEMBL30698077 | 0.87 | TSHR (0.35) | TSHRCNR1DAGLACA12CA14 | |
| SCHEMBL5807050 | 0.85 | TSHR (0.41) | TSHRTRPV1ALDH1A1 | |
| SCHEMBL5807047 | 0.85 | TSHR (0.41) | TSHRTRPV1ALDH1A1 | |
| SCHEMBL27293618 | 0.83 | TSHR (0.37) | TSHRCA12CA14MEN1KMT2A | |
| SCHEMBL5814139 | 0.82 | CA12 (0.54) | TSHRCA12CA14MEN1KMT2A | |
| SCHEMBL5814134 | 0.82 | CA12 (0.54) | TSHRCA12CA14MEN1KMT2A | |
| SCHEMBL21547821 | 0.81 | CA12 (0.39) | TSHRCA12CA14MEN1KMT2A | |
| SCHEMBL5812685 | 0.80 | CNR1 (0.44) | TSHRCNR1DAGLAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060251597-A1 | ANTI-ODOR COMPOSITIONS AND THERAPEUTIC USE | YU RUEY J | 2006-11-09 | — | — | US | claimed |
| US-20240216539-A1 | VECTOR FOR DELIVERING ACTIVE AGENT TO NERVOUS SYSTEM, AND USE THEREOF | INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (KR) | 2024-07-04 | — | — | US | disclosed |
| US-20240216539-A1 | VECTOR FOR DELIVERING ACTIVE AGENT TO NERVOUS SYSTEM, AND USE THEREOF | INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (KR) | 2024-07-04 | — | — | US | disclosed |
| WO-2006119283-A2 | ANTI-ODOR COMPOSITIONS AND THERAPEUTIC USE | YU RUEY J (US) | 2006-11-09 | — | — | WO | disclosed |
| US-20060251597-A1 | ANTI-ODOR COMPOSITIONS AND THERAPEUTIC USE | YU RUEY J | 2006-11-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240216539-A1 | VECTOR FOR DELIVERING ACTIVE AGENT TO NERVOUS SYSTEM, AND USE THEREOF | TTR, HAVCR2, PMP22 | TSHR 383/4885CNR1 3435/4885DAGLA 4058/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.